Page 7 of 8
Chemical Science
Figure 7SI). The proposed binding mode shows that the first and
55 Notes and references
third methyl group are surfaceꢀexposed, enabling them to be
involved in recognition of the TCR, whereas the remaining
methyl groups are buried in the A’ channel. The additional
methyl branches of 1 could enhance the strength of the interaction
with CD1b and also have an influence on the conformation of the
whole molecule, in particular the surfaceꢀexposed methyl groups
that might interact with the TCR. This is also supported by
structureꢀfunctional studies performed using analogues of 1 with
aStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7,
NL-9747 AG Groningen, The Netherlands. E-mail: a.j.minnaard@rug.nl
bExperimental Immunology, Department of Biomedicine, University
Hospital Basel, Hebelstrasse 20, CH-4031, Basel, Switzerland
60 cCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), 205
route de Narbonne BP 64182, F-31077 Toulouse, France
dUniversité de Toulouse, UPS, IPBS, F-31077 Toulouse, France
eSingapore Immunology Network (SIgN), Agency for Science, Technology
and Research (A*STAR), Biopolis, Singapore.
5
10 less methyl groups.24
65
† Electronic Supplementary Information (ESI) available: HPLC traces,
spectroscopic characterization, modeling studies and experimental details.
See DOI: 10.1039/b000000x/
Given the presumed degree of flexibility in the CD1b binding
groove, the modeling was repeated while leaving the side chains
lining the pocket flexible. Only a few aminoꢀacid side chains
moved to a small extent, illustrating how CD1b is capable of
15 accommodating lipids with different numbers, patterns and types
of substituents (aminoꢀacid residues in question shown as sticks
in Figure 5). This observation is in agreement with the results
reported in the literature and suggests that Tꢀcell activation by
CD1b is controlled by its threeꢀdimensional structure as well as
20 the way in which the polar head group and some of the methyl
groups of 1 are presented to the TCR.50ꢀ52
70
75
1
A. Koul, E. Arnoult, N. Lounis, J. Guillemont, K. Andries, Nature,
2011, 469, 483.
C.E. Barry, J.S. Blanchard, Curr. Opin. Chem. Biol., 2010, 14, 456.
M.J. Brennan, J. Thole, Tuberculosis, 2012, 92, S6.
M. Daffé, J.ꢀM. Reyrat, The mycobacterial cell envelope; ASM
Press: Washington, DC, 2008.
2
3
4
5
6
D.E. Minnikin, L. Kremer, L.G. Dover, G.S. Besra, Chem. Biol.,
2002, 9, 545.
7
8
9
M. Jackson, G. Stadthagen, B. Gicquel, Tuberculosis, 2007, 87, 78.
M.B. Goren, Biochim. Biophys. Acta, 1970, 210, 116.
M.B. Goren, Biochim. Biophys. Acta, 1970, 210, 127.
80
Conclusions
10 The synthesis of a sulfolipidꢀI analogue was reported earlier: C.D.
Leigh, C.R. Bertozzi, J. Org. Chem., 2008, 73, 1008.
11 J.P. Brozna, M. Horan, J.M. Rademacher, K.M. Pabst, M.J. Pabst,
Inf. Immun., 1991, 59, 2542.
Hydroxyphthioceranic acid 4 has been prepared, for the first time,
via two different routes. The most efficient route afforded the
25 product in 3.0% yield over 32 steps and its stereochemistry was
established by comparison with that of the natural product. The
highestꢀyielding synthesis is based on a very efficient catalytic
iterative protocol for the stereoselective introduction of methyl
substituents, a highly stereoselective catalytic allylic substitution
30 and a extremely stereoselective platinumꢀcatalyzed diboration
reaction. This result was used for the first synthesis of Ac2SGL, a
complex glycolipid isolated from M. tuberculosis. The synthesis
is based on a regioselective functionalization of trehalose, and a
carefully devised protectingꢀgroup strategy. Ac2SGL was
35 prepared in seven steps from trehalose with an overall yield of
4.1% based on 4, and its structure was identical to that of the
natural product. Biological evaluation revealed that the antigenic
potency of synthetic 1 is identical to that of the natural product.
Together with earlier studies on model compounds, this implies
40 that the precise structure and stereochemistry of the
hydroxyphthioceranic acid part in 1 are important for its antigenic
activity. As Ac2SGL (1) is an extremely potent antigen, studies
on its application as a vaccine against tuberculosis are of utmost
importance and can now be performed with the pure synthetic
45 material available. Modeling studies of natural Ac2SGL give an
indication on the influence of altering the complex side chain of
Ac2SGL on binding. This approach could be valuable for the
development of future analogues.
85
12 M.B. Goren, O. Brokl, W.B. Schaeffe, Infect. Immun., 1974, 9, 142.
13 Y. Okamoto, Y. Fujita, T. Naka, M. Hirai, I. Tomiyasu, I. Yano,
Microb. Pathog., 2006, 40, 245.
14 L. Zhang, M.B. Goren, T.J. Holzer, B.R. Andersen, Inf. Immun.,
1988, 56, 2876.
90
15 M. Kato, M.B. Goren, Inf. Immun., 1974, 10, 733.
16 O. Marjanovic, A.T. Iavarone, L.W. Riley, J. Microbiol., 2011, 49,
441.
17 S.E. Converse, J.D. Mougous, M.D. Leavell, J.A. Leary, C.R.
Bertozzi, J.S. Cox, Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 6121.
18 P. Domenech, M.B. Reed, C.S. Dowd, C. Manca, G. Kaplan, C.E.
Barry, J. Biol. Chem., 2004, 279, 21257.
95
19 C. Rousseau, O.C. Turner, E. Rush, Y. Bordat, T.D. Sirakova, P.E.
Kolattukudy, S. Ritter, I.M. Orme, B. Gicquel, M. Jackson, Inf.
Immun., 2003, 71, 4684.
20 S.A. Gilmore, M.W. Schelle, C.M. Holsclaw, C.D. Leigh, M. Jain,
S.J. Cox, J.A. Leary,C.R. Bertozzi, ACS Chem. Biol., 2012, 7, 863.
21 Compound 1 was isolated as a mixture of homologues with a chain
length varying from 22 to 42 carbons and the number of 1,3ꢀmethyl
groups varying from 3 to 12. The depicted structure of 1 corresponds
to the most abundant SGL.
100
105
22 M. Gilleron, S. Stenger, Z. Mazorra, F. Wittke, S. Mariotti, G.
Bohmer, J. Prandi, L. Mori, G. Puzo, G. De Libero, J. Exp. Med.,
2004, 199, 649.
110 23 D.C. Barral, M.B. Brenner, Nat. Rev. Immunol., 2007, 7, 929.
24 J. Guiard, A. Collmann, L.F. GarciaꢀAlles, L. Mourey, T. Brando, L.
Mori, M. Gilleron, J. Prandi, G. De Libero, G. Puzo, J. Immunol.,
2009, 182, 7030.
25 The following report was used as the guideline for this part: J.
115
Guiard, A. Collmann, M. Gilleron, L. Mori, G. De Libero, J. Prandi,
G. Puzo, Angew. Chem. Int. Ed., 2008, 47, 9734.
50 Acknowledgements
26 R.P. van Summeren, D.B. Moody, B.L. Feringa, A.J. Minnaard, J.
Am. Chem. Soc., 2006, 128, 4546.
27 R.D. Mazery, M. Pullez, F. Lopez, S.R. Harutyunyan, A.J. Minnaard,
B.L. Feringa, J. Am. Chem. Soc., 2005, 127, 9966.
28 B. ter Horst, B.L. Feringa, A.J.Minnaard, Chem. Commun., 2007, 5,
489.
29 B. ter Horst, B.L. Feringa, A.J. Minnaard, Org. Lett., 2007, 9, 3013.
We thank Dr. Laura Kliman from the group of Prof. Morken for
her advice on the asymmetric diboration/dihydroxylation.
Financial support from The Netherlands Organization for
Scientific Research (NWOꢀCW) is acknowledged.
120
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 7